PT1196188E - Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv - Google Patents

Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv

Info

Publication number
PT1196188E
PT1196188E PT00947514T PT00947514T PT1196188E PT 1196188 E PT1196188 E PT 1196188E PT 00947514 T PT00947514 T PT 00947514T PT 00947514 T PT00947514 T PT 00947514T PT 1196188 E PT1196188 E PT 1196188E
Authority
PT
Portugal
Prior art keywords
fcv
treatment
monoclonal antibodies
related diseases
vgf
Prior art date
Application number
PT00947514T
Other languages
English (en)
Inventor
Hai Yan
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of PT1196188E publication Critical patent/PT1196188E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
PT00947514T 1999-07-21 2000-07-19 Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv PT1196188E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14474399P 1999-07-21 1999-07-21

Publications (1)

Publication Number Publication Date
PT1196188E true PT1196188E (pt) 2005-10-31

Family

ID=22509932

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00947514T PT1196188E (pt) 1999-07-21 2000-07-19 Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv

Country Status (11)

Country Link
EP (1) EP1196188B1 (pt)
JP (1) JP2003505428A (pt)
AT (1) ATE298244T1 (pt)
AU (1) AU779614B2 (pt)
CA (1) CA2378845A1 (pt)
DE (1) DE60020970T2 (pt)
DK (1) DK1196188T3 (pt)
ES (1) ES2244456T3 (pt)
MX (1) MXPA02000678A (pt)
PT (1) PT1196188E (pt)
WO (1) WO2001007074A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1373905A2 (de) * 2001-04-06 2004-01-02 BioVisioN AG Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien
US7749716B2 (en) * 2004-05-18 2010-07-06 Vermilllion, Inc. Methods of detecting a fragment of neurosecretory protein VGF for diagnosing alzheimer's disease
JPWO2006118313A1 (ja) * 2005-04-27 2008-12-18 武田薬品工業株式会社 新規ポリペプチドおよびその用途
EP1939286A4 (en) * 2005-07-29 2009-05-20 Kyowa Hakko Kirin Co Ltd NEW PEPTIDE
GB201201332D0 (en) * 2012-01-26 2012-03-14 Imp Innovations Ltd Method

Also Published As

Publication number Publication date
AU779614B2 (en) 2005-02-03
JP2003505428A (ja) 2003-02-12
MXPA02000678A (es) 2002-07-02
CA2378845A1 (en) 2001-02-01
ATE298244T1 (de) 2005-07-15
ES2244456T3 (es) 2005-12-16
EP1196188B1 (en) 2005-06-22
DE60020970T2 (de) 2006-05-11
DE60020970D1 (de) 2005-07-28
AU6110300A (en) 2001-02-13
WO2001007074A1 (en) 2001-02-01
DK1196188T3 (da) 2005-11-07
EP1196188A1 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
FI963101A (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
DK0996463T3 (da) Katalytiske monoklonale antistoffer med proteaseaktivitet til selektiv lysis af proteinbestanddelen af plaques og aggregater beslægtet med patologiske tilstande
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE60028970D1 (de) An her2 bindende peptidverbindungen
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
BG109311A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNFAL, AND HIS APPLICATION
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
WO2001070977A3 (en) Fibroblast growth factor receptor-like molecules and uses thereof
WO2002000724A3 (en) Thymic stromal lymphopoietin receptor molecules and uses thereof
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
WO2001079164A3 (en) N-substituted dithiocarbamates for the treatment of biological disorders
MXPA02008239A (es) Gen humano de la esquizofrenia.
ATE235551T1 (de) Ligand (tie ligand-4) vom tie-2 rezeptor und dessen verwendungen
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
AU9363398A (en) Hepatitis c receptor protein cd81
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
PT1196188E (pt) Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
WO2004083241A3 (en) Btc-interacting proteins and use thereof
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
AU2001235761A1 (en) Diagnosis of breast cancer using bcmp-11 as marker
WO2001074903A3 (en) Cd20/ige-receptor like molecules and uses thereof
WO2003055980A3 (en) Il-17 like molecules and uses thereof
MXPA03010728A (es) Moleculas de proteina-2 relacionadas con b7 y uso de las mismas.